Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 4;18(19):e202300344.
doi: 10.1002/cmdc.202300344. Epub 2023 Jul 24.

Back in Person: Frontiers in Medicinal Chemistry 2023

Matthias Gehringer  1 , Felix Pape  2 , María Méndez  3 , Philipp Barbie  4 , Andrea Unzue Lopez  5 , Julien Lefranc  5 , Franca-Maria Klingler  6 , Gerhard Hessler  7 , Thierry Langer  8 , Eleonora Diamanti  9 , Matthias Schiedel  10
Affiliations

Back in Person: Frontiers in Medicinal Chemistry 2023

Matthias Gehringer et al. ChemMedChem. .

Abstract

The Frontiers in Medicinal Chemistry (FiMC) is the largest international Medicinal Chemistry conference in the German speaking area and took place from April 3rd to 5th 2023 in Vienna (Austria). Fortunately, after being cancelled in 2020 and two years (2021-2022) of entirely virtual meetings, due to the COVID-19 pandemic, the FiMC could be held in a face-to-face format again. Organized by the Division of Medicinal Chemistry of the German Chemical Society (GDCh), the Division of Pharmaceutical and Medicinal Chemistry of the German Pharmaceutical Society (DPhG), together with the Division of Medicinal Chemistry of the Austrian Chemical Society (GÖCH), the Austrian Pharmaceutical Society (ÖPhG), and a local organization committee from the University of Vienna headed by Thierry Langer, the meeting brought together 260 participants from 21 countries. The program included 38 lectures by leading scientists from industry and academia as well as early career investigators. Moreover, 102 posters were presented in two highly interactive poster sessions.

Keywords: chemical biology; conference; drug design; drug discovery; medicinal chemistry.

PubMed Disclaimer

References

    1. J. Bröker, A. G. Waterson, C. Smethurst, D. Kessler, J. Böttcher, M. Mayer, G. Gmaschitz, J. Phan, A. Little, J. R. Abbott, Q. Sun, M. Gmachl, D. Rudolph, H. Arnhof, K. Rumpel, F. Savarese, T. Gerstberger, N. Mischerikow, M. Treu, L. Herdeis, T. Wunberg, A. Gollner, H. Weinstabl, A. Mantoulidis, O. Krämer, D. B. McConnell, S. W. Fesik, J. Med. Chem. 2022, 65, 14614-14629.
    1. A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation - Full Text View - www.clinicaltrials.gov.
    1. A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors - Full Text View - www.clinicaltrials.gov.
    1. Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration - Full Text View - www.clinicaltrials.gov.
    1. None

Publication types

LinkOut - more resources